PITUITARY-FUNCTION IS ALTERED DURING THE SAME CYCLE IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME TREATED WITH CONTINUOUS OR CYCLIC ORAL-CONTRACEPTIVES OR A GONADOTROPIN-RELEASING-HORMONE AGONIST
Ea. Ruchhoft et al., PITUITARY-FUNCTION IS ALTERED DURING THE SAME CYCLE IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME TREATED WITH CONTINUOUS OR CYCLIC ORAL-CONTRACEPTIVES OR A GONADOTROPIN-RELEASING-HORMONE AGONIST, Fertility and sterility, 66(1), 1996, pp. 54-60
Objective: To determine if continuous oral contraceptive (OC) therapy
was superior to a cyclic regimen in achieving persistent pituitary sup
pression of LH in patients with polycystic ovary syndrome (PCOS). Desi
gn: Fourteen women (ages 16 to 41 years) with PCOS received one of thr
ee treatment groups: continuous OC therapy (30 mu g ethinyl E(2) plus
150 mu g desogestrel), cyclic OC therapy, or monthly injections of a G
nRH agonist (GnRH-a, leuprolide acetate depot 3.75 mg) for 3 months. B
asal hormone levels were obtained before initiating therapy, on days 1
5 to 17 of the 3rd month of treatment (study 1) and again on days 26 t
o 28 of the 3rd month (study 2). A GnRH stimulation test was also perf
ormed during study 1 and study 2. Results: After 3 months of treatment
, LH levels were decreased significantly in all groups with less effec
tive suppression observed in the cyclic OC group compared with the con
tinuous OC or GnRH-a groups. A significant rise in LH was found only i
n the cyclic OC group after 5 to 7 days of placebo treatment (study 1
versus study 2). An increase in T was also observed in the cyclic OC g
roup during study 2, whereas the continuous OC and GnRH-a groups showe
d continued inhibition of T levels. Although there was no significant
difference in LII area under the curve (AUG) measurements after GnRH s
timulation in study 1 versus study 2, the LH AUC was significantly gre
ater in both studies in the cyclic OC group compared with the continuo
us OC or GnRH-a groups. Conclusions: Increased LH secretion during the
week of placebo in the cyclic OC group was associated with a concomit
ant increase in T. The striking rise in LH secretion after GnRH stimul
ation in the cyclic OC group may represent increased pituitary sensiti
vity in patients receiving cyclic OCs regardless of the phase of the t
reatment cycle, perhaps secondary to increased pituitary stores of LH
in these women.